| Move Together Boston Feasibility Pilot (Sit Less, Move More App for Black Breast Cancer Survivors & At-Risk Relatives) (NCT05011279) | Dana-Farber Cancer Institute | 2021-09-10 |
| Near Infrared Spectroscopy (NIRS) as a Method for Measuring Oxidative Capacity of Skeletal Muscle Mitochondria in Breast Cancer and All Gynecological Cancer Patients (NCT06672497) | University of South Carolina | 2021-09-07 |
| Opening the Conversation Study (NCT04806724) | Oregon State University | 2021-09-01 |
| The Effect of Art Therapy on Pain, Emesis, Anxiety and Quality of Life, Breast Cancer (NCT05666583) | Cumhuriyet University | 2021-09-01 |
| Exercise Regimen Designed to Improve Functional Mobility, Body Composition, and Strength After Breast Conservation Therapy for Women With Early Stage Breast Cancer (NCT04449809) | Duke University | 2021-09-01 |
| Deep Inspiration Breath-hold Radiotherapy for Left-sided Breast Cancer (NCT05200078) | Shu lian Wang | 2021-09-01 |
| Multicentric Study for External Validation of a Deep Learning Model for Mammographic Breast Density Categorization (NCT05021055) | Hospital Italiano de Buenos Aires | 2021-09-01 |
| Meditation and Cancer, Pilot Feasibility Study (MAEva Pilot Study) (NCT04751201) | Institut de Cancérologie de Lorraine | 2021-09-01 |
| Oncoliq: Test for Early Breast Cancer Detection. (NCT04906330) | Hospital Militar Central Cirujano Mayor Dr. Cosme Argerich | 2021-09-01 |
| Artificial Intelligence Analysis for Magnetic Resonance Imaging in Screening Breast Cancer in High-risk Women (NCT04996615) | Peking University People's Hospital | 2021-09-01 |
| Spatial Location of Breast Cancer Local Recurrence After Mastectomy (NCT06130111) | Maastricht Radiation Oncology | 2021-09-01 |
| Stereotactic Radiosurgery vs Whole Brain Radiotherapy in Breast Cancer With Brain Oligometastasis (NCT05144867) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2021-08-31 |
| Application of CT-Linac-Based "All-in-One" One-Stop Radiotherapy in Breast Cancer (NCT07776301) | Fudan University | 2021-08-27 |
| Study of Cardiopulmonary Exercise Testing in Women Who Have HER2-Positive Breast Cancer With Mild Cardiotoxicity (NCT05036252) | Memorial Sloan Kettering Cancer Center | 2021-08-27 |
| Investigating the Diagnostic Potential of Tear Proteins in Cancer - A Pilot Study (NCT05223218) | Namida Lab | 2021-08-25 |
| Remote Electronic Assessment of Survivors With Feedback Communication and Directed Referrals (NCT05047575) | University of Wisconsin, Madison | 2021-08-24 |
| Circulating Tumor DNA Enriched, Genomically Directed Post-neoadjuvant Trial for Patients With Residual Triple Negative Breast Cancer (NCT04849364) | Bryan Schneider, MD | 2021-08-24 |
| Use of an Interactive 3D Tool During Consultation for Breast Reconstruction Surgery (NCT05025020) | Memorial Sloan Kettering Cancer Center | 2021-08-23 |
| Real-World Outcomes of US Talazoparib-Treated Patients With Locally Advanced or Metastatic Breast Cancer (NCT04987931) | Pfizer | 2021-08-20 |
| Evaluating Harms and Benefits of Endocrine Therapy in Patients ≥70 Years of Age With Lower Risk Breast Cancer (NCT04921137) | Ottawa Hospital Research Institute | 2021-08-19 |
| Facilitating Adaptive Coping With Fear of Recurrence Among Breast Cancer Survivors (NCT05364450) | Indiana University | 2021-08-17 |
| Postoperative Identification of Tumor Cells At the Lumpectomy Site of Patients with Early Breast Cancer (NCT04339517) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2021-08-17 |
| Dose Escalation and Expansion Study of SAR443216 in Participants With Relapsed/Refractory HER2 Expressing Solid Tumors (NCT05013554) | Sanofi | 2021-08-16 |
| Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI) (NCT04568616) | Dartmouth-Hitchcock Medical Center | 2021-08-13 |
| A Study to Investigate the Safety, Tolerability, of APG-2575 as a Single Agent or in Combination for Breast Cancer (NCT04946864) | Ascentage Pharma Group Inc. | 2021-08-13 |
| Taking AIM at Breast Cancer (NCT04720209) | Dana-Farber Cancer Institute | 2021-08-13 |
| Single Fraction Accelerated Partial Breast Irradiation vs. Five Fraction Accelerated Partial Breast Irradiation for Low-risk Stage 0 and I Breast Carcinoma (NCT04849871) | Washington University School of Medicine | 2021-08-12 |
| A Study of PRT1419 in Patients With Advanced Solid Tumors (NCT04837677) | Prelude Therapeutics | 2021-08-11 |
| A Single Arm Pilot Study to Refine a Novel Approach to Exercise Promotion Based on Affect-regulation (NCT04903249) | Dartmouth-Hitchcock Medical Center | 2021-08-10 |
| Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment (NCT04803084) | Laura Kennedy | 2021-08-09 |
| Study of KN026 in Combination With Docetaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer (NCT04881929) | Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 2021-08-09 |
| Biology Guided Therapy for Breast Cancer for ER Positive (NCT04965688) | Inova Health Care Services | 2021-08-08 |
| Supporting Women With Breast Cancer to Prepare for Treatment (The Prepare Study) (NCT07221071) | Endeavor Health | 2021-08-05 |
| Design and Evaluation of the Effects of a Physical Therapy Program With Digital Support in Patients With Breast Cancer (NCT04837248) | Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal | 2021-08-02 |
| SHR6390 Combined With Anastrozole for Preoperative Treatment of Breast Cancer. (NCT04836520) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-02 |
| Minimal Invasive Breast Cancer Excision Using Vacuum Assisted Biopsy Under Ultrasound Guidance (NCT04107636) | Radboud University Medical Center | 2021-08-02 |
| Precision Breast Conserving Surgery With Guidance. (NCT05708664) | The First Affiliated Hospital with Nanjing Medical University | 2021-08-01 |
| The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study (NCT06220630) | First Affiliated Hospital, Sun Yat-Sen University | 2021-08-01 |
| Breast Cancer and Kinesiophobia and Physical Activity (NCT05090098) | Acibadem University | 2021-08-01 |
| TIPOPS (Telemedicine vs In Person Oncology Patient Surveillance) (NCT04936243) | Dana-Farber Cancer Institute | 2021-08-01 |
| Breast Mesh Used in Two-staged Breast Reconstruction (NCT04967976) | Tianjin Medical University Cancer Institute and Hospital | 2021-08-01 |
| Trastuzumab Combined With Pertuzumab for Adjuvant Treatment of Breast Cancer After Neoadjuvant Therapy (NCT04973319) | Shengjing Hospital | 2021-08-01 |
| Effect of Telemonitoring on Functionality, Quality of Life and Risk of Lymphedema in Breast Cancer Survivors (NCT04779450) | University of the State of Santa Catarina | 2021-08-01 |
| Insulin Sensitivity After Breast Cancer (NCT05010356) | University of Copenhagen | 2021-08-01 |
| Neoadjuvant Dose-dense Chemotherapy for HR+/HER2- Breast Cancer Patients With High Proliferation Index (NCT05728268) | Shantou Central Hospital | 2021-08-01 |
| Copenhagen Master Observational Trial (NCT05145244) | Rigshospitalet, Denmark | 2021-08-01 |
| Magnetic Tracer in the Sentinel Node Procedure in Breast Cancer: the Non-radioactive Alternative for Radio-isotopes (NCT05122585) | Zuyderland Medisch Centrum | 2021-08-01 |
| Observational Analysis of Palbociclib Treatment in Patients With First Line Therapy for Locally Advanced and/or Metastatic Breast Cancer (NCT04874025) | Hospital San Carlos, Madrid | 2021-07-31 |
| Single Fraction Preoperative Radiotherapy for Early Stage Breast Cancer (NCT04679454) | European Institute of Oncology | 2021-07-31 |
| Development of a Personalized Discussion Prioritization Tool for Older Adults Considering Adjuvant Chemotherapy for Breast Cancer (NCT05073432) | University of Rochester | 2021-07-28 |
| Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection (Lipodox®) in Chinese Patients (NCT05273944) | Shenzhen Kangzhe Pharmaceutical Co., Ltd. | 2021-07-28 |
| A Prospective Observational Study to Describe Clinical Outcomes, Treatment Patterns, Patients Characteristics Among Patients With HR+/HER2- Advanced BC Initiating Treatment With Risarg®, Piqray®, Endocrine Therapy or Chemotherapy in Routine Clinical Practice in Russia (NCT04943497) | Novartis Pharmaceuticals | 2021-07-27 |
| Observational Study of Effectiveness and Safety of Trastuzumab Emtansine (T-DM1) in HER2-positive Breast Cancer Patients With Residual Invasive Disease Following Neoadjuvant Chemotherapy and Anti-HER2 Target Therapy (NCT05754502) | Consorzio Oncotech | 2021-07-27 |
| Biopsy of Calcifications Under Contrast Enhancement Guide (BoCCE) (NCT04862429) | Azienda USL Reggio Emilia - IRCCS | 2021-07-27 |
| Integrated Patient Avatars for Guiding Systemic Therapy Treatments in Metastatic Breast Cancer Patients (NCT04608357) | Sunnybrook Health Sciences Centre | 2021-07-21 |
| Radiation, Immunotherapy and PARP Inhibitor in Triple Negative Breast Cancer (NCT04837209) | Massachusetts General Hospital | 2021-07-21 |
| Sj-subway, a Predictor for the Recurrence of High-risk Hormone Receptor-positive Breast That is Sensitive to Extended Endocrine Therapy (NCT04476485) | Shengjing Hospital | 2021-07-19 |
| Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy (NCT04137640) | Shengjing Hospital | 2021-07-19 |
| Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer (NCT04136782) | Shengjing Hospital | 2021-07-19 |
| Predicting Chronic Pain Following Breast Surgery (NCT04967352) | University of California, San Diego | 2021-07-19 |
| Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCT (NCT04137653) | Shengjing Hospital | 2021-07-19 |
| A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours (NCT04969835) | Avacta Life Sciences Ltd | 2021-07-16 |
| Lighting Intervention for Cancer-related Fatigue (NCT04827446) | University of Michigan Rogel Cancer Center | 2021-07-15 |
| The Effect of RadiaAce Gel in the Prevention and Treatment of Radiation Dermatitis in Breast Cancer Patients (NCT04481802) | AceTech | 2021-07-14 |
| Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy (NCT04724499) | Dana-Farber Cancer Institute | 2021-07-14 |
| Oncoliq: Early Breast Cancer Detection Based on Liquid Biopsies and microRNAs (NCT06439940) | Oncoliq US Inc | 2021-07-14 |
| Study of the Sexual Health of Patients Treated for Breast Cancer and Followed up in the Observatory of Fertility at Jeanne de Flandre Hospital. (NCT04852926) | University Hospital, Lille | 2021-07-13 |
| Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive Early or Locally Advanced Breast Cancer: a Single-arm, Non-randomized, Single-center, Open Label Trial (NCT05165225) | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2021-07-13 |
| Injection Regimen Trial of PEG-rhG-CSF During Breast Cancer Chemotherapy (NCT04477616) | The First Affiliated Hospital with Nanjing Medical University | 2021-07-13 |
| Neoadjuvant Ontruzant (SB3) in Patients With HER2-positive Early Breast Cancer: An Open-Label (NeoON) (NCT05036005) | Institut fuer Frauengesundheit | 2021-07-11 |
| Contrast-Free Magnetic Resonance Imaging for Breast Disease (NCT05006196) | Perspectum | 2021-07-06 |
| Shared Decision Making in Surveillance for Distant Metastasis in Breast Cancer (NCT04862078) | Seoul National University Hospital | 2021-07-06 |
| Investigation of a Digital Healthy Habits Program for Individuals With Breast Cancer (NCT04967209) | Noom Inc. | 2021-07-05 |
| Transitioning Care: Perspectives of Older Women With Early Breast Cancer on Current Telemedicine Modalities (NCT04990934) | UNC Lineberger Comprehensive Cancer Center | 2021-07-02 |
| Compare Continuation of Original Targeted Therapy With Trastuzumab Combined With Pyrotinib and Capecitabine as Postoperative Adjuvant Therapy in Non-pCR Patients With HER2 Positive Early Breast Cancer (NCT05292742) | Fujian Medical University Union Hospital | 2021-07-02 |
| To Evaluate the Cardiac Safety of Pegylated Liposomal Doxorubicin Concurrently Plus Trastuzumab and Pertuzumab in the Adjuvant Setting for Early-stage HER-2-positive Breast Cancer: a Multicenter, Randomized Controlled Clinical Study (NCT05656079) | Shanghai Pudong Hospital | 2021-07-01 |
| RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer (NCT04972448) | Zhejiang Cancer Hospital | 2021-07-01 |
| Safety of Continuing HER-2 Directed Therapy in Overt Left Ventricular Dysfunction (NCT04680442) | Population Health Research Institute | 2021-07-01 |
| Pembrolizumab and Paclitaxel in Hormone Receptor-positive, hyperMUTATted Metastatic Breast Cancer Identified by Whole exOme sequeNcing ('MUTATION2') (NCT04946227) | Yonsei University | 2021-07-01 |
| of Androgen Receptor Expression in Breast Cancer With or Without BRCA Mutation (NCT05404334) | Banaras Hindu University | 2021-07-01 |
| Stage I HER2 Positive Invasive Breast Cancer De-escalation Study(IRIS-C/D) (NCT04922008) | Fudan University | 2021-07-01 |
| Aromatherapy Methods in Reducing Anxiety Before Breast Biopsy (NCT05276505) | Acibadem University | 2021-07-01 |
| The Effect of a Patient Decision Aids for Breast Cancer Screening (NCT04948983) | Pontificia Universidad Catolica de Chile | 2021-07-01 |
| Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer (NCT04906395) | Tolmar Inc. | 2021-07-01 |
| Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy (NCT04495387) | University of Florence | 2021-07-01 |
| Improving Survivorship Among Minority Cancer Dyads (NCT04685551) | Charles Drew University of Medicine and Science | 2021-07-01 |
| A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors (NCT04875806) | NextCure, Inc. | 2021-06-30 |
| Evaluating the Dose Timing (Morning vs Evening) of Endocrine Therapy and Its Effects on Tolerability and Compliance (NCT04864405) | Ottawa Hospital Research Institute | 2021-06-30 |
| Interpretations and Predictions of Patient Reported Outcomes by Breast Cancer Patients (NCT05064098) | University of Colorado, Denver | 2021-06-29 |
| Effectiveness of AI Genetic Counseling Program vs In-person Genetic Counseling in Breast Cancer (NCT04354675) | Case Comprehensive Cancer Center | 2021-06-29 |
| Inetetamab Plus Cyclophosphamide Metronomic Chemotherapy Plus Aromatase Inhibitor in Metastatic HER2+/HR+ Breast Cancer (NCT04941885) | Sun Yat-sen University | 2021-06-25 |
| The ClearCoast™ Magnetic Resonance Outcome PMS Study (NCT05458739) | Clear Cut Medical Ltd. | 2021-06-24 |
| Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer (NCT04623554) | Zealand University Hospital | 2021-06-23 |
| A Study of T-DXd in Participants With or Without Brain Metastasis Who Have Previously Treated Advanced or Metastatic HER2 Positive Breast Cancer (NCT04739761) | AstraZeneca | 2021-06-22 |
| Patient Recall of Cancer Screening and Diagnosis (NCT05014295) | Case Comprehensive Cancer Center | 2021-06-22 |
| Hypofractionation With Simultaneous Integrated Boost for Early Breast Cancer (NCT04913532) | Capital Medical University | 2021-06-22 |
| Online Psychosocial Cancer Screening, Monitoring and Stepped Treatment in Cancer Survivors (NCT04372459) | Institut Català d'Oncologia | 2021-06-21 |
| IIT2020-20-SHIRAZIP-WALK: Nature Walks (NCT04896580) | Cedars-Sinai Medical Center | 2021-06-21 |
| Validation of Scales in Reconstructive Breast Surgery (NCT05233891) | Vastra Gotaland Region | 2021-06-21 |
| Fulvestrant Plus Anlotinib in HR(+)/HER2(-) Metastatic Breast Cancer With FGFR Mutation (NCT04936295) | Sun Yat-sen University | 2021-06-16 |